What is CAGR? What does CAGR table indicate for Trimurthi Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Trimurthi Ltd Stock Analysis

Q: Is Trimurthi Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Trimurthi Ltd and arrived at the following conclusion.

Q: Is the current market price of Trimurthi Ltd a good price to buy it?

The 5-year analysis of Trimurthi Ltd's performance infers.

Small Cap

Evaluated by 55 users | BSE: 536565 | NSE: |
Trading

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis P

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Capital Employed	6.09%	5.26%	4.02%	3.73%	1.46%	0.62%	0.51%	1.8%	1.34%	0.54%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	16.5	11.7	6	5.7	1.5	0.9	3.5	3.1	3.6	1
Y-o-Y Gr. Rt.	-	-29.2%	-49%	-3.7%	-74.6%	-36.3%	277.4%	-11.4%	15.4%	-71.3%
Adjusted EPS (Rs.)	0.7	0.62	0.47	0.51	0.2	0.09	0.07	0.26	0.2	0.08
Y-o-Y Gr. Rt.	-	-11.4%	-24.2%	8.5%	-60.8%	-55%	-22.2%	271.4%	-23.1%	-60%
Book Value per Share (Rs.)	11.65	11.99	13.62	14.13	14	14.12	14.31	14.6	14.83	14.9
Adjusted Net Profit	0.5	0.4	0.4	0.4	0.2	0.1	0.1	0.2	0.2	0.1
Net Op. Cash Flow (Rs. Cr.)	-0.6	-0.4	-3.5	0	-0.4	2	-1.1	1.1	-0.4	1.2
Debt to Cash Flow from Ops	-0.26	-0.21	-0.02	1.26	0	0	0	0	0	0

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Trimurthi Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Trimurthi Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	-26.5%	-6.7%	-33.6%	-71.3%
Adjusted EPS	-21.4%	-16.7%	4.6%	-60%
Book Value per Share	2.8	1.3	1.4	0.5
Share Price	-11.8%	-5.1%	-8%	201%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Equity (%)	6.09	5.24	3.99	3.7	1.43	0.62	0.51	1.8	1.34	0.54
Operating Profit Margin (%)	2.13	6.29	13.86	15.43	47.7	42.72	5.21	15.3	5.02	-27.62
Net Profit Margin (%)	2.86	3.57	6.41	7.24	11.2	7.53	1.68	6.77	4.43	6.28
Debt to Equity	0.02	0.01	0.01	0	0	0	0	0	0	0
Working Capital Days	135	273	645	620	2,364	3,301	859	1,033	890	2,851
Cash Conversion Cycle	41	94	155	71	145	25	32	85	153	796

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	64.19%
Non-Institutions	35.81%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Trimurthi Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Trimurthi Ltd a good price to buy it?

The 5-year analysis of Trimurthi Ltd's performance infers:

Trimurthi Ltd earnings have declined by -16.7%, whereas share price has depreciated -5.1% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

3. What is Trimurthi Ltd share price return in the past 10 years ?

We analysed the performance of Trimurthi Ltd share prices over the last 10 years. Here is what we found out:

Trimurthi Ltd share price has depreciated -14.1% annually over the past ten years.

About Company

Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Companyâ€™s range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness.

2012 -The Company entered

2012 -The Company entered into a Manufacturing Agreement with M/s. Bharat Parenterals Limited, Vadodara, Gujrat for exclusive manufacture of Company's 12 products for export. The Company entered into Distribution Agreement with Zyanya Global Pte Limited, Vietnam for selling the Company's Products in Vietnam.

Business areas of the company:

The company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products.

Divisions:

Pharma Business, Financial Services, Investment in Shares and Trading in Shares

Read Less